Related Experiment Video
Updated: Oct 8, 2025

11:38
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
Published on: July 2, 2016
10.7K
Mesenchymal Stromal Cells: a Possible Reservoir for HIV-1?
K Kallmeyer1,2, M A Ryder1,2, M S Pepper3,4
1Department of Immunology, Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria, South Africa.
Stem Cell Reviews and Reports
|January 1, 2022
Summary
Mesenchymal stromal cells (MSCs) may harbor latent HIV-1, contributing to viral persistence. Further research is needed to confirm MSCs as a definitive HIV-1 reservoir, crucial for developing curative therapies.
Area of Science:
- Virology
- Immunology
- Stem Cell Biology
Background:
- Antiretroviral therapy (ART) suppresses HIV-1 but does not eliminate viral reservoirs.
- Cellular reservoirs cause viral rebound and hinder HIV-1 cure strategies.
- Mesenchymal stromal/stem cells (MSCs) are under investigation as potential HIV-1 reservoirs.
Purpose of the Study:
- To review existing literature on MSCs' potential role in the HIV-1 reservoir.
- To assess evidence for MSCs harboring latent HIV-1.
- To identify knowledge gaps for future research on HIV-1 persistence.
Main Methods:
- Literature review of studies investigating MSCs and HIV-1.
- Analysis of MSC expression of HIV-1 entry receptors and co-receptors.
- Evaluation of studies on HIV-1 and HIV-1 protein effects on MSC properties.
Main Results:
- MSCs express receptors and co-receptors for HIV-1 entry, with variable expression levels.
- In vitro exposure to HIV-1 alters MSC proliferation and differentiation.
- Studies confirming latent integrated proviral DNA in MSCs are lacking.
Conclusions:
- MSCs show potential to contribute to the HIV-1 reservoir.
- Definitive proof of MSCs as an HIV-1 reservoir requires further investigation.
- MSCs might play a role in HIV-1 persistence in vasculature, adipose tissue, and bone marrow.
Related Concept Videos
Mesenchymal Stem Cells
5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K

